Form 8-K - Current report:
SEC Accession No. 0001445305-14-003559
Filing Date
2014-08-08
Accepted
2014-08-08 17:02:08
Documents
3
Period of Report
2014-08-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K q220148k-earningsrelease.htm 8-K 26870
2 EXHIBIT 99.1 EARNINGS RELEASE q22014-ex991earningsrelease.htm EX-99.1 211847
3 cumberlandpharmaimage.jpg GRAPHIC 37721
  Complete submission text file 0001445305-14-003559.txt   291870
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 141028165
SIC: 2834 Pharmaceutical Preparations